cerca CERCA
Mercoledì 21 Aprile 2021
Aggiornato: 06:15
Temi caldi


New Findings from AAIC Indicated Brain-Gut Axis to be the New Breakthrough in the Research Field of Alzheimer's Disease

SHANGHAI, July 29, 2020 /PRNewswire/ -- Alzheimer's disease has been an unsolved puzzle for scientists since the first patient was found over 100 years ago. Different theories like cholinergic hypothesis, amyloid cascade hypothesis, and tau protein hypothesis have made progress in research but failed to bring new therapies to patients. In recent years scientists started to focus on the brain-gut axis, with its breakthrough in the fields of Parkinson's disease, depression and autism. Data linking ...

CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Inhalation Products.

SUZHOU, China, July 2, 2020 /PRNewswire/ -- CF PharmTech, Inc. ("CF PharmTech") announced today that it has raised US $50M in Series F financing following its US $90M Series E financing in January of 2020, in total, successfully completing an equity investment deal of nearly US $140M within six months. The investors participated in the Series F financing include BioTrack Capital, CICC Qichen, CICC Qide, SAIC Hengxu, GP M&A Fund and Watson Investment. Its existing investors including Passion Capit...

Approcci multidisciplinari all'avanguardia per la cura al cancro minimamente invasiva con l'utilizzo di JCI MN COLLOIDAL IODINE (R) e possibili effetti su SARS-CoV-2

TOKYO, 26 giugno 2020 /PRNewswire/ -- Il 10 giugno 2020, JCI MN IODINE Co., Ltd. ha pubblicato la seguente nuova informativa sull'utilità terapeutica degli agenti JCI MN IODINE. Ryusuke Fujiki, direttore clinico e presidente del Fujiki Hospital, ha annunciato "il trattamento minimamente invasivo e multidisciplinare per il cancro che ha mostrato risultati sensazionali con l'utilizzo degli agenti JCI MN IODINE."

Agilyx agrees to an exclusive collaboration with TechnipFMC to enable new pathways for post-use polystyrene to enhance the circular economy

PORTLAND, Oregon, June 25, 2020 /PRNewswire/ -- Agilyx Corporation ("Agilyx"), the leader in chemical recycling of post-use plastics back into polymers, chemicals and low carbon fuels, today announced the exclusive collaboration with TechnipFMC to jointly develop a process to purify Agilyx Styrene Oil to high purity styrene. This collaboration has been the result of over a year of evaluation, and their desire to expand their energy transition and circular economy offerings.

ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA

SAN DIEGO, June 22, 2020 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company developing a new generation of BRAF inhibitor, today announced that the first cancer patient has been successfully enrolled and dosed with ABM-1310 in the Phase 1 clinical trial in the USA. ABM-1310, the company's lead candidate, demonstrated superior properties in pre-clinical animal models, is a highly selective, highly water-soluble, orally active, and brain-penetrant small molecule BRAF inhib...

The Shepherd Color Company Announces New IR Black for Recycling of Black Plastic

CINCINNATI, June 17, 2020 /PRNewswire/ -- It seems that the Shepherd Color's R&D team is at it again. 'Creating Value, Brightening Lives' has long been the Core Value of The Shepherd Color Company. The R&D Team has their pulse on the coatings and plastics industries to understand the needs of their customers: to create quality, innovative products, which bring value to not only their customers, but to the sustainability of the environment.

ora in
Prima pagina
Tag più usati
in questa pagina

change in emea region



leadership change

partner di canale

prodotti imdsoft

servizi metavision

sistema informativo

in Evidenza